Literature DB >> 4207990

Carbamazepine for epilepsy. A controlled prospective evaluation.

J J Cereghino, J T Brock, J C Van Meter, J K Penry, L D Smith, B G White.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4207990     DOI： 10.1212/wnl.24.5.401

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  36 in total

1.  Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: a double-blind controlled study.

Authors:  T Okuma; K Inanaga; S Otsuki; K Sarai; R Takahashi; H Hazama; A Mori; M Watanabe
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

Review 2.  Phenobarbitone versus phenytoin monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nevitt; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2019-07-31

Review 3.  Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data.

Authors:  Sarah J Nevitt; Maria Sudell; Jennifer Weston; Catrin Tudur Smith; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2017-06-29

Review 4.  Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review.

Authors:  Sarah J Nolan; Anthony G Marson; Jennifer Weston; Catrin Tudur Smith
Journal:  Cochrane Database Syst Rev       Date:  2016-12-15

5.  Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11-epoxide in epileptic patients.

Authors:  J J MacKichan; P K Duffner; M E Cohen
Journal:  Br J Clin Pharmacol       Date:  1981-07       Impact factor: 4.335

6.  Plasma levels of carbamazepine and carbamazepine-10,11-epoxide during treatment of epilepsy.

Authors:  M Eichelbaum; L Bertilsson; L Lund; L Palmér; F Sjöqvist
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

7.  Recent advances in drug therapy for epilepsy.

Authors:  J Bruni
Journal:  Can Med Assoc J       Date:  1979-04-07       Impact factor: 8.262

Review 8.  Clinical pharmacokinetics of carbamazepine.

Authors:  L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1978 Mar-Apr       Impact factor: 6.447

9.  Pediatrics-epitomes of progress: carbamazepine (tegretol) in the treatment of epilepsy.

Authors:  R J Schain
Journal:  West J Med       Date:  1978-03

10.  Carbamazepine and its 10,11-epoxide in children and adults with epilepsy.

Authors:  S Pynnönen; M Sillanpää; H Frey; E Iisalo
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.